NIH-funded research R01 grant

New approaches to protect the heart after pneumococcal pneumonia

Official title: Novel strategies to mitigate cardiac damage and dysfunction following invasive pneumococcal disease

Funded at Louisiana State Univ Hsc Shreveport · NIH-11443379 · Data updated 2026-11-12

Aims to find ways to prevent heart damage and later heart problems in adults hospitalized with pneumonia caused by Streptococcus pneumoniae.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLouisiana State Univ Hsc Shreveport
NIH-funded
Lab location1 site (Shreveport, United States)
Project startOctober 21, 2025
Project endApril 30, 2028
Funding year2026
Award (this year)$547,431
NIH project number7R01HL171136-03
Project IDNIH-11443379 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be adults with pneumococcal pneumonia or a history of severe pneumonia who are at risk for cardiovascular complications.

Less likely to help

People without pneumonia or those not at risk for heart complications from pneumonia may not benefit from this research.

What this research studies

Many adults hospitalized for community-acquired pneumonia have a high risk of dangerous heart events during and after their hospital stay. This project tests strategies to reduce heart inflammation and damage caused by the infection, focusing on a specific inflammatory pathway that appears to worsen heart function in animal models. By studying how the heart responds in the setting of pneumococcal disease, the researchers hope to identify targets to prevent long-term heart problems after pneumonia. The work is conducted at Louisiana State University Shreveport, led by Hind Lal, and involves collaboration across disciplines to translate findings toward patient care.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that protect the heart during and after severe pneumonia, reducing death and long-term heart problems.

How similar studies have gone: Previous work has shown heart inflammation contributes to damage in pneumococcal disease, but targeted heart-protective strategies are still under development.

Where this research is happening

  • Louisiana State Univ Hsc Shreveport
    Shreveport, United States
    Active

Researchers

  • Principal investigator: Lal, Hind — Louisiana State Univ Hsc Shreveport
  • Study coordinator: Lal, Hind

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.